About the IQ Consortium®

The International Consortium for Innovation and Quality in Pharmaceutical Development (IQ Consortium® or IQ) is a technically-focused organization of pharmaceutical and biotechnology companies with a mission of advancing science and technology to augment the capability of member companies to develop transformational solutions that benefit patients, regulators and the broader R&D community.

Our Work

The IQ Consortium has ongoing initiatives that span the drug development process: we are active in the areas of chemistry, manufacturing and control; preclinical safety; drug metabolism; clinical pharmacology; quality; and the reduction, refinement, and replacement of animal testing. Within the IQ Consortium:

You can learn more about current our current focus and activities by reading our Strategic Plan and exploring the Initiatives section of our website.

Engaging with the Broader Scientific and Regulatory Communities

The IQ Consortium believes in collaboration – within our organization and within the scientific and regulatory community more broadly. We make a practice of sharing our work and seeking to facilitate constructive scientific exchange through publications, scientific conferences, workshops and roundtables. We also welcome opportunities to collaborate directly with organizations and individuals outside of IQ member companies, and have established active partnerships with governmental bodies, other trade groups, and academic researchers.